Citi Opens 90d Downside Catalyst Watch on Sarepta Therapeutics (NASDAQ: SRPT)The analyst comments "We are opening a 90-day downside short-term ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE